Rare diseases and orphan drugs – from research to marketing authorization

Orphan drugs are medicinal products indicated for the treatment, diagnosis, and prevention of rare diseases. Currently, 6 % to 8 % of people in the world have some rare disease. So, the need for medicinal products that will provide hope and a chance for the treatment of affected patients, is immense. Research and development of […]